Participants will receive monthly MRI exams. No further information is available on these possible upcoming studies, as they are in the early planning stages. Enrollment is closed. Participants will receive monthly MRI exams. Oral Copaxone Study ongoing.
Enrollment is closed.
This study evaluates the efficacy of oral Copaxone in reducing relapse rates and new MRI lesions. Enrollment is closed. This trial will determine whether Copaxone is effective in slowing the progression of primary progressive multiple sclerosis. The study lasts three years and participants will receive annual MRI exams. Enrollment is closed.